Chandrakant Bagul

807 total citations
30 papers, 700 citations indexed

About

Chandrakant Bagul is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Chandrakant Bagul has authored 30 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 13 papers in Molecular Biology and 7 papers in Computational Theory and Mathematics. Recurrent topics in Chandrakant Bagul's work include Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (9 papers) and Computational Drug Discovery Methods (7 papers). Chandrakant Bagul is often cited by papers focused on Synthesis and biological activity (18 papers), Cancer therapeutics and mechanisms (9 papers) and Computational Drug Discovery Methods (7 papers). Chandrakant Bagul collaborates with scholars based in India, China and United States. Chandrakant Bagul's co-authors include Ähmed Kamal, Veena Nayak, Vunnam Srinivasulu, Narayana Nagesh, Alka Rao, Manda Sathish, N. V. Subba Reddy, Nagula Shankaraiah, Siddiq Pasha Shaik and M.V.P.S. Vishnuvardhan and has published in prestigious journals such as Food Research International, European Journal of Medicinal Chemistry and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Chandrakant Bagul

29 papers receiving 691 citations

Peers

Countries citing papers authored by Chandrakant Bagul

Since Specialization

Citations

This map shows the geographic impact of Chandrakant Bagul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandrakant Bagul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandrakant Bagul more than expected).

Fields of papers citing papers by Chandrakant Bagul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandrakant Bagul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandrakant Bagul. The network helps show where Chandrakant Bagul may publish in the future.

Co-authorship network of co-authors of Chandrakant Bagul

This figure shows the co-authorship network connecting the top 25 collaborators of Chandrakant Bagul. A scholar is included among the top collaborators of Chandrakant Bagul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandrakant Bagul. Chandrakant Bagul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Insights into Salicylate Synthase: From Medicinal Chemistry Perspective 2024 ·Indian Journal of Pharmaceutical Education and Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Subhash L. Bodhankar, Chandrakant Bagul, Dileep Kumar, (unknown), Raghavendra V. Kulkarni, Vaibhav Shinde, (unknown)	2
2	Reconnoitering imidazopyridazines as anticancer agents based on virtual modelling approach: quantitative structure activity relationship, molecular docking and molecular dynamics 2023 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), (unknown), Chandrakant Bagul, (unknown), Dilip Kumar, (unknown)	5
3	Machine learning facilitated structural activity relationship approach for the discovery of novel inhibitors targeting EGFR 2023 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), (unknown), (unknown), Chandrakant Bagul, (unknown)	7
4	Evaluation of wound healing effect of Mallotus philippensis (Lam.) Mull. Arg. by in silico multitargets directed for multiligand approach 2022 ·In Silico Pharmacology ·(unknown), Chandrakant Bagul, Vaibhav Shinde	5
5	Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents 2022 ·Molecular Diversity ·Chandrakant Bagul, Koteswara Rao Garikapati, (unknown), (unknown), Jaki R. Tamboli, Ravikumar Akunuri, Siddiq Pasha Shaik, Manika Pal‐Bhadra, Ähmed Kamal	7
6	Phyto-metabolomics of phlogacanthus thyrsiformis by using LC-ESI-QTOF-MS/MS and GC/QTOF-MS: Evaluation of antioxidant and enzyme inhibition potential of extracts 2022 ·Food Research International ·(unknown), Upadhyayula Suryanarayana Murty, Chandrakant Bagul, Roshan M. Borkar, P. Radhakrishnanand	14
7	Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives 2022 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·(unknown), Chandrakant Bagul, Dileep Kumar, (unknown), Achaiah Garlapati, (unknown)	24
8	Cyclic adenosine monophosphate: Recent and future perspectives on various diseases 2022 ·Journal of Applied Pharmaceutical Science ·(unknown), (unknown), (unknown), Chandrakant Bagul, (unknown), (unknown), (unknown), (unknown), (unknown)	4
9	Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents 2022 ·Anti-Cancer Agents in Medicinal Chemistry ·(unknown), Chandrakant Bagul, Dileep Kumar, Achaiah Garlapati, (unknown), (unknown), (unknown)	3
10	Investigation of structure–activity relationship: In silico studies of [1, 2, 4]triazolo[4, 3-a]pyridine ureas as P38 kinase inhibitors 2022 ·Structural Chemistry ·(unknown), (unknown), Chandrakant Bagul, (unknown), (unknown)	3
11	Design and synthesis of 1,2,3-triazolo linked benzo[d]imidazo[2,1-b]thiazole conjugates as tubulin polymerization inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Siddiq Pasha Shaik, M.V.P.S. Vishnuvardhan, Faria Sultana, Alka Rao, Chandrakant Bagul, (unknown), Jeevak Sopanrao Kapure, Nishant Jain, Ahmed Kamal	27
12	Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents 2017 ·MedChemComm ·Chandrakant Bagul, Koteswara Rao Garikapati, (unknown), Jaki R. Tamboli, Manika Pal‐Bhadra, Ahmed Kamal	51
13	Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers 2016 ·Bioorganic & Medicinal Chemistry ·Alka Rao, (unknown), Siddiq Pasha Shaik, Veena Nayak, T. Srinivasa Reddy, (unknown), Thokhir Basha Shaik, Chandrakant Bagul, Ähmed Kamal	54
14	2-aryl benzimidazole conjugate induced apoptosis in human breast cancer MCF-7 cells through caspase independent pathway 2016 ·APOPTOSIS ·Veena Nayak, Narayana Nagesh, Ameeta RaviKumar, Chandrakant Bagul, M.V.P.S. Vishnuvardhan, Vunnam Srinivasulu, Ähmed Kamal	17
15	Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors 2016 ·Bioorganic Chemistry ·Alka Rao, (unknown), N. V. Subba Reddy, T. Srinivasa Reddy, Siddiq Pasha Shaik, Chandrakant Bagul, Ähmed Kamal	39
16	Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability 2015 ·Bioorganic & Medicinal Chemistry ·Ähmed Kamal, Manda Sathish, Veena Nayak, Vunnam Srinivasulu, (unknown), Yellaiah Tangella, Dinesh Thummuri, Chandrakant Bagul, Nagula Shankaraiah, Narayana Nagesh	90
17	Investigation of the mechanism and apoptotic pathway induced by 4β cinnamido linked podophyllotoxins against human lung cancer cells A549 2015 ·APOPTOSIS ·Ähmed Kamal, Veena Nayak, Chandrakant Bagul, M.V.P.S. Vishnuvardhan, Adla Mallareddy	14
18	Design and Synthesis of C3‐Pyrazole/Chalcone‐Linked Beta‐Carboline Hybrids: Antitopoisomerase I, DNA‐Interactive, and Apoptosis‐Inducing Anticancer Agents 2014 ·ChemMedChem ·Ähmed Kamal, Vunnam Srinivasulu, Veena Nayak, Manda Sathish, Nagula Shankaraiah, Chandrakant Bagul, N. V. Subba Reddy, Nandini Rangaraj, Narayana Nagesh	81
19	Anti-tubercular agents. Part 7: A new class of diarylpyrrole–oxazolidinone conjugates as antimycobacterial agents 2013 ·European Journal of Medicinal Chemistry ·Ähmed Kamal, (unknown), Rajesh V.C.R.N.C. Shetti, Anver Basha Shaik, M. Rao, (unknown), Inshad Ali Khan, Sandeep Sharma, Nitin Pal Kalia, Sunil Kumar, Chandrakant Bagul	24
20	Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs) 2013 ·European Journal of Medicinal Chemistry ·(unknown), M. Ravinder, Pankaj K. Bagul, (unknown), Chandrakant Bagul, Jagadeesh Babu Nanubolu, K. Srinivas, S. Banerjee, V. Jayathirtha Rao	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact